PALO ALTO, Calif., Aug. 5, 2021 /PRNewswire/ -- Varian, a Siemens
Healthineers company, announced today that cancer patients in
Australia will be the first in the
world to benefit from streamlined, coordinated cancer care
facilitated by an upcoming release of the ARIA® oncology information system (OIS)
with new multi-disciplinary functionality. Australia's Icon Group will become the first
in the world to deploy this new system, which is scheduled for
release in Australia and other
global sites in early 2022.
Icon plans to go live with its first location in 2022. After a
successful deployment, the new ARIA system will serve as Icon's
next-generation platform for enhancing clinical operations, and
further deployments at other Icon sites will commence. The
longer-term plan is to install this integrated solution across
Icon's global footprint of 44 locations over several years.
Icon will also be the first in the Australian and Asia/Pacific regions to deploy Varian's
Noona® electronic
patient-reported outcomes (ePRO) solution, a digital application
that enables real-time patient engagement and seamlessly integrates
with the new ARIA release.
Mark Middleton, CEO, Icon Group,
said, "Icon is delighted to once again be at the forefront of
technology evolution alongside Varian. As a global provider of
comprehensive cancer care, having systems that address the breadth
of our operations is vital to seamless patient care. Varian's new
solution will ensure we continue to advance clinical efficiency,
quality assurance, and information security, and it will enhance
our team's ability to focus on the most important part of their day
– their patients."
Icon, a long-time and experienced user of ARIA for the
management of radiation oncology, is expanding its use of the
software to also manage medical oncology. By adding the Noona ePRO
application, Icon will be able to integrate patient-reported
outcomes data into its patient care practices.
"Icon has chosen a combination of integrated tools that will
provide its clinical teams with multiple benefits, including
efficient and standardized clinical workflows, a cloud-based
software-as-a-service operations model, and the ability to use
real-time symptom information to manage the patient's cancer
treatment journey more proactively," said Kenneth Tan, president, Asia Pacific and Japan, Varian. "We are proud to be working
with Icon Group, a dedicated group of professionals who are
committed to bringing the latest innovations to their
patients."
ARIA is Varian's comprehensive oncology information system for
managing clinical, administrative, and financial processes in
comprehensive cancer treatment environments. It interconnects
clinical functions and provides clinical staff members with
up-to-the-minute information for making important clinical
decisions quickly at every point in a patient's course of
treatment.
About Varian
At Varian, a Siemens Healthineers
company, we envision a world without fear of cancer. For more than
70 years, we have developed, built and delivered innovative cancer
care technologies and solutions for our clinical partners around
the globe to help them treat millions of patients each year. With
an Intelligent Cancer Care approach, we are harnessing advanced
technologies like artificial intelligence, machine learning and
data analytics to enhance cancer treatment and expand access to
care. Our 11,000 employees across 70 locations keep the patient and
our clinical partners at the center of our thinking as we power new
victories in cancer care. Because, for cancer patients everywhere,
their fight is our fight. For more information, visit
http://www.varian.com/ and follow @VarianMedSys on
Twitter.
About Icon Group
Icon Group is Australia's largest
dedicated cancer care provider, with a global reach into
Singapore, Mainland China,
Hong Kong and New Zealand. Icon has 48 centres across its
global footprint, including 44 cancer centres covering the full
spectrum of cancer treatment modalities and clinical research,
alongside 4 centres broadening services into specialist care,
surgical oncology and health screening. Icon's oncology offering is
augmented by the Group's pharmacy and compounding capabilities,
which are underpinned by Slade Health, Epic Pharmacy and Slade
Pharmacy. For more information visit www.icongroup.global and
follow us at Icon Group on LinkedIn.
Press Contact
Lynne
Tran
Corporate Communications
publicrelations@varian.com
Investor Relations Contact
Siemens Healthineers
Investor Relations
View original
content:https://www.prnewswire.com/news-releases/icon-group-first-in-world-to-adopt-new-multi-disciplinary-oncology-information-system-from-varian-301348909.html
SOURCE Varian